Chemoinformaics analysis of GANODERIC-ACID-S-1
| Molecular Weight | 612.804 | nRot | 8 |
| Heavy Atom Molecular Weight | 560.388 | nRig | 25 |
| Exact Molecular Weight | 612.366 | nRing | 4 |
| Solubility: LogS | -4.898 | nHRing | 0 |
| Solubility: LogP | 4.697 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 96 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 36 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 101.209 |
| nHD | 1 | BPOL | 60.8468 |
| QED | 0.18 |
| Synth | 5.543 |
| Natural Product Likeliness | 2.77 |
| NR-PPAR-gamma | 0.926 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.974 |
| Pgp-sub | 0.003 |
| HIA | 0.257 |
| CACO-2 | -4.911 |
| MDCK | 0.00000951 |
| BBB | 0.385 |
| PPB | 0.972877 |
| VDSS | 1.113 |
| FU | 0.0406283 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.83 |
| CYP2c9-inh | 0.066 |
| CYP2c9-sub | 0.454 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.13 |
| CYP3a4-inh | 0.19 |
| CYP3a4-sub | 0.434 |
| CL | 1.46 |
| T12 | 0.122 |
| hERG | 0.022 |
| Ames | 0.003 |
| ROA | 0.021 |
| SkinSen | 0.085 |
| Carcinogencity | 0.152 |
| EI | 0.008 |
| Respiratory | 0.814 |
| NR-Aromatase | 0.175 |
| Antiviral | Yes |
| Prediction | 0.738414 |